Psychedelics Optimi Health enters $1.2M psilocybin distribution agreement The mushroom cultivator will be supplying a private client for clinical research purposes Rowan DunneMay 4, 2023
Psychedelics Psyched Wellness Amanita muscaria extract shows potential for brain health improvement The study found that the extract activates specialized cells within the brain Rowan DunneMay 3, 2023
News MAPS launches online education program on psychedelics The new school aims to provide education on psychedelic medicines to promote safe, legal and equitable access Natalia Buendia CalvilloMay 3, 2023
News PharmAla Biotech and Vitura Health form joint psychedelics venture in Australia To help the new venture get started, Vitura has agreed to provide up to $2.2 million in loans Natalia Buendia CalvilloMay 2, 2023
Psychedelics University of Exeter launches postgrad psychedelics certificate program The online program 'Psychedelics: Mind, Medicine, and Culture' was announced at the Breaking Convention conference last week Rowan DunneApril 28, 2023
Stock News Reunion Neuroscience struggles to maintain Nasdaq listing requirements The company has until mid-October to fulfill the requirements before the exchange takes further action Rowan DunneApril 26, 2023
News Mindset Pharma files patents for non-hallucinogenic, ‘psychedelic-inspired’ drugs The company believes the drugs have the potential to treat children and seniors Natalia Buendia CalvilloApril 26, 2023
Psychedelics Incannex orders psilocybin and MDMA from PharmAla Biotech Incannex plans to open a series of psychedelics clinics in Australia and use PharmAla's products Rowan DunneApril 25, 2023
Psychedelics International psychedelics market to reach US$8.3B by 2027: ReportLinker The market was valued at US$4.83B this year and will rise with a CAGR of 14.5 per cent Rowan DunneApril 24, 2023
Psychedelics Mydecine’s MDMA with rapid onset and a short duration shows promising results The effects from the company's MYCO-006 compounds last for only two hours and set in four times as fast Rowan DunneApril 24, 2023